P. Beaudry

783 total citations
35 papers, 553 citations indexed

About

P. Beaudry is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, P. Beaudry has authored 35 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in P. Beaudry's work include Respiratory Support and Mechanisms (7 papers), Schizophrenia research and treatment (6 papers) and Cystic Fibrosis Research Advances (6 papers). P. Beaudry is often cited by papers focused on Respiratory Support and Mechanisms (7 papers), Schizophrenia research and treatment (6 papers) and Cystic Fibrosis Research Advances (6 papers). P. Beaudry collaborates with scholars based in Canada, New Zealand and United States. P. Beaudry's co-authors include Paul B. Pencharz, Alexandre Dumas, Réjean Fontaine, Allan L. Coates, L Annable, G Chouinard, Guy Chouinard, James G. Connolly, Raezelle Zinman and Mary Corey and has published in prestigious journals such as The Lancet, Journal of Applied Physiology and The Journal of Pediatrics.

In The Last Decade

P. Beaudry

35 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Beaudry Canada 15 260 156 73 72 54 35 553
Ben Green United Kingdom 14 240 0.9× 90 0.6× 17 0.2× 90 1.3× 25 0.5× 29 674
F Pajno-Ferrara Italy 7 61 0.2× 74 0.5× 18 0.2× 56 0.8× 40 0.7× 9 407
L Alexandre France 17 165 0.6× 383 2.5× 10 0.1× 50 0.7× 82 1.5× 36 778
Gulnur Com United States 16 277 1.1× 82 0.5× 26 0.4× 183 2.5× 20 0.4× 34 523
Erwin Oei United States 11 127 0.5× 16 0.1× 24 0.3× 72 1.0× 63 1.2× 14 662
Erin Kelly Canada 13 59 0.2× 93 0.6× 20 0.3× 92 1.3× 20 0.4× 33 577
Giorgio R. Sansone United States 13 84 0.3× 60 0.4× 30 0.4× 76 1.1× 13 0.2× 25 464
D. Stamm France 11 83 0.3× 18 0.1× 87 1.2× 124 1.7× 11 0.2× 42 576
M. A. H. Russell United Kingdom 8 118 0.5× 16 0.1× 35 0.5× 347 4.8× 23 0.4× 14 621
Rongyuan Zheng China 13 42 0.2× 200 1.3× 23 0.3× 19 0.3× 95 1.8× 47 561

Countries citing papers authored by P. Beaudry

Since Specialization
Citations

This map shows the geographic impact of P. Beaudry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Beaudry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Beaudry more than expected).

Fields of papers citing papers by P. Beaudry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Beaudry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Beaudry. The network helps show where P. Beaudry may publish in the future.

Co-authorship network of co-authors of P. Beaudry

This figure shows the co-authorship network connecting the top 25 collaborators of P. Beaudry. A scholar is included among the top collaborators of P. Beaudry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Beaudry. P. Beaudry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chouinard, Guy, et al.. (1994). Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 18(7). 1129–1141. 35 indexed citations
2.
Lapierre, Y.D., R. J. Ancill, George Awad, et al.. (1992). A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.. PubMed. 17(4). 134–45. 9 indexed citations
3.
Awad, A. George, Y.D. Lapierre, N.P.V. Nair, et al.. (1991). The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial. Schizophrenia Research. 4(3). 311–312. 1 indexed citations
4.
Chouinard, Guy, et al.. (1990). Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(3). 431–438. 7 indexed citations
5.
Zinman, Raezelle, Mary Corey, Allan L. Coates, et al.. (1989). Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. The Journal of Pediatrics. 114(3). 368–377. 77 indexed citations
6.
Fontaine, Réjean, P. Beaudry, Linda Beauclair, & Guy Chouinard. (1987). Comparison of withdrawal of buspirone and diazepam: A placebo controlled study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 11(2-3). 189–197. 19 indexed citations
7.
Beaudry, P.. (1987). Cystic fibrosis--clinical viewpoint--a disease that doesn't make sense.. PubMed. 254. 1–5. 3 indexed citations
8.
Parsons, Hannah, P. Beaudry, & Paul B. Pencharz. (1985). The Effect of Nutritional Rehabilitation on Whole Body Protein Metabolism of Children with Cystic Fibrosis. Pediatric Research. 19(2). 189–192. 14 indexed citations
9.
Beaudry, P., Réjean Fontaine, Guy Chouinard, & L Annable. (1985). An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 9(5-6). 589–592. 8 indexed citations
10.
Coates, Allan L., et al.. (1984). Relationship between the partial pressure of arterial oxygen and airflow limitation in children with cystic fibrosis.. PubMed. 131(4). 325–6. 5 indexed citations
11.
Turpin, E, et al.. (1984). Modification of biological activities of Ricinus communis agglutinin by cross-linking with formaldehyde. Canadian Journal of Biochemistry and Cell Biology. 62(4). 203–208. 8 indexed citations
12.
Fontaine, Réjean & P. Beaudry. (1984). Panic attacks and panic disorders.. PubMed. 30. 1383–8. 5 indexed citations
13.
14.
Taussig, Lynn M., et al.. (1976). TREATMENT OF LARYNGOTRACHEOBRONCHITIS (CROUP). USE OF INTERMITTENT POSITIVE-PRESSURE BREATHING AND RACEMIC EPINEPHRINE. Survey of Anesthesiology. 20(3). 237–237. 4 indexed citations
15.
Landau, Lou I., Lynn M. Taussig, Peter T. Macklem, & P. Beaudry. (1975). Contribution of inhomogeneity of lung units to the maximal expiratory flow-volume curve in children with asthma and cystic fibrosis.. PubMed. 111(6). 725–31. 32 indexed citations
16.
Corbet, Anthony, et al.. (1975). Effect of positive-pressure breathing on aADN2 in hyaline membrane disease. Journal of Applied Physiology. 38(1). 33–38. 10 indexed citations
17.
Corbet, Anthony, et al.. (1975). The Effect of Age on Arterial–Alveolar Nitrogen Difference in Normal Adults. Canadian Journal of Physiology and Pharmacology. 53(1). 63–66. 2 indexed citations
18.
Outerbridge, E.W., Miklós Nógrády, P. Beaudry, & L Stern. (1973). IDIOPATHIC RESPIRATORY DISTRESS SYNDROME. RECURRENT RESPIRATORY ILLNESS IN SURVIVORS. Survey of Anesthesiology. 17(1). 41–41. 1 indexed citations
19.
Beaudry, P., et al.. (1973). Pulmonary function studies in idiopathic pulmonary hemosiderosis in children.. PubMed. 107(3). 410–5. 17 indexed citations
20.
Joncas, J. H., R. J. Williams, Laurent Berthiaume, P. Beaudry, & V. Pavilanis. (1969). DIAGNOSIS OF VIRAL RESPIRATORY INFECTIONS BY ELECTRON MICROSCOPY. The Lancet. 293(7602). 956–959. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben Green Breakdown of academic impact, for papers by F Pajno-Ferrara Breakdown of academic impact, for papers by L Alexandre Breakdown of academic impact, for papers by Gulnur Com Breakdown of academic impact, for papers by Erwin Oei Breakdown of academic impact, for papers by Erin Kelly Breakdown of academic impact, for papers by Giorgio R. Sansone Breakdown of academic impact, for papers by D. Stamm Breakdown of academic impact, for papers by M. A. H. Russell Breakdown of academic impact, for papers by Rongyuan Zheng
Rankless by CCL
2026